Clinical trial
Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Adolescents and Adult Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.
NCT02316847 is registered in ClinicalTrials.gov with Acorda Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Adolescents and Adult Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.
- Lead sponsor
- Acorda Therapeutics
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2014
- Completion date
- September 30, 2016
- Enrollment
- 126 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.